Disparities in Pancreatic Ductal Adenocarcinoma—The Significance of Hispanic Ethnicity, Subgroup Analysis, and Treatment Facility on Clinical Outcomes
Open Access
- 13 April 2020
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 9 (12) , 4069-4082
Abstract
Background: Disparities exist among patients with pancreatic ductal adenocarcinoma (PDAC). Non‐White race is regarded as a negative predictor of expected treatment and overall survival. Data suggest that Academic Research Programs (ARP) provide better outcomes for minorities, but ethnic/minority outcomes are underreported. We hypothesize that outcomes among racially/ethnically diverse PDAC patients may be influenced by treatment facility.Methods: The National Cancer Database was used to identify 170,327 patients diagnosed with PDAC between 2004 and 2015. Cox proportional‐hazard regression was used to compare survival between race/ethnic groups across facilities.Results: In unadjusted models, compared to non‐Hispanic Whites (NHW), non‐Hispanic Blacks (NHB) had the worst overall survival (HR = 1.05, 95%CI: 1.03‐1.06, P < .001) and Hispanics had the best overall survival (HR = 0.92, 95%CI: 0.90‐0.94, P < .001). After controlling for socioeconomic and clinical covariates, NHB (HR = 0.95, 95%CI: 0.93‐0.96, P < .001) had better overall survival compared to NHW, and Hispanics continued to have the best comparative outcomes (HR = 0.84, 95%CI: 0.82‐0.86, P < .001). Among Hispanics, Dominicans and South/Central Americans lived the longest, at 10.25 and 9.82 months, respectively. The improved survival in Hispanics was most pronounced at ARP (HR = 0.80, 95%CI: 0.77‐0.84, P < .001) and Integrated Network Cancer Programs (HR = 0.78, 95%CI: 0.73‐0.84, P < .001). NHB had improved survival over NHW at Comprehensive Community Care Programs (HR = 0.96, 95%CI: 0.93‐0.98, P = .002) and ARP (HR = 0.96, 95%CI: 0.94‐0.98, P = .001), which was influenced by income, education, and surgical resection.Conclusion: Survival was improved at ARP for all populations. Hispanics had the best comparative overall survival. NHB had improved overall survival at higher volume centers, but this was dependent upon income, education, and surgical resection.Keywords
Funding Information
- National Cancer Institute (U54CA233444)
- National Institutes of Health
- American College of Surgeons
This publication has 17 references indexed in Scilit:
- Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancerCancer Medicine, 2018
- Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinomaHPB, 2017
- Racial disparities in pancreatic neuroendocrine tumors survival: a SEER studyCancer Medicine, 2017
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- Pancreatic resectionCancer, 2009
- National Failure to Operate on Early Stage Pancreatic CancerAnnals of Surgery, 2007
- Racial/Ethnic Differences in Physician Distrust in the United StatesAmerican Journal of Public Health, 2007
- Racial Differences in Pancreatic Cancer: Comparison of Survival and Histologic Types of Pancreatic Carcinoma in Asians, Blacks, and Whites in the United StatesPancreas, 2000
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987